SUTRO BIOPHARMA, INC. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sutro Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Sutro Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was -97 %, a 5.82% increase year-over-year.
  • Sutro Biopharma, Inc. annual Return On Equity for 2023 was -70.9 %, a 30.4% decline from 2022.
  • Sutro Biopharma, Inc. annual Return On Equity for 2022 was -54.4 %, a 48.4% decline from 2021.
  • Sutro Biopharma, Inc. annual Return On Equity for 2021 was -36.7 %, a 147% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -70.9 -16.5 -30.4% Jan 1, 2023 Dec 31, 2023
2022 -54.4 -17.7 -48.4% Jan 1, 2022 Dec 31, 2022
2021 -36.7 -21.8 -147% Jan 1, 2021 Dec 31, 2021
2020 -14.9 +89.3 +85.7% Jan 1, 2020 Dec 31, 2020
2019 -104 -158 -294% Jan 1, 2019 Dec 31, 2019
2018 53.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.